Alamar Biosciences, Inc. (California) (ALMR)
27.52
-1.16
(-4.04%)
USD |
NASDAQ |
Nov 20, 10:22
Alamar Biosciences Cash from Investing (Quarterly) : 11.74M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 11.74M |
| June 30, 2026 | -120.80M |
| March 31, 2026 | -0.778M |
| Date | Value |
|---|---|
| September 30, 2025 | 14.19M |
| June 30, 2025 | 17.94M |
| March 31, 2025 | 17.02M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Personalis, Inc. | 24.01M |
| 10X Genomics, Inc. | -0.503M |
| Champions Oncology, Inc. | -0.055M |
| Medpace Holdings, Inc. | -20.14M |
| Avantor, Inc. | -38.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.73M |
| Cash from Financing (Quarterly) | -9.849M |
| Free Cash Flow | -67.04M |
| Free Cash Flow Per Share (Quarterly) | -0.2213 |
| Free Cash Flow to Equity (Quarterly) | -6.318M |
| Free Cash Flow to Firm (Quarterly) | -15.22M |
| Free Cash Flow Yield | -3.51% |